Concordia Healthcare Corp. T.CXR.R

Valeant Salix

[ryehigh2014]

Anyone have any opinions on this? This is HUGE for VRX if they seal the deal. Basically unwinding. 

Curious however:
- Salix has $900MM Expected EBITDA for 2017 
- Its IBS drug Xifafen has competition 
- Its portfolio is also subject to regulatory risk and political risk

So if Takeda sees value despite this than the pharma sector obviously has value. Thoughts on Salix anyone?

[MegaBear]

This post has been removed in accordance with Community Policy

[SpankedOnPaper]

What significant gain on CXR? .  CXR was down 2%.  And you Are HAPPY? If we saw a 30% gain because someone wanted to buy a core asset  (which I doubt it because no one wants our off-patent drugs and our core asset isn't even fda approved) then that would be a $1.30 jump.   Yes, a whole dollar and thirty cents. WOW HOLY MOTHER OF GOD I THINK I WILL BE ABLE TO RETIRE

[MustardTiger88]

I'm confused as to why this is good news for Valeant.  Didn't they buy Salix last year for almost $15 billion?